Biochemical Engineering Special Interest Group
biological engineering professionals
18 April 2017

Cobra Biologics to pump $19M into its UK and Swedish production facilities

Cobra Biologics will inject $19 million into facilities located in the U.K. and Sweden to help the CDMO meet increased demand from gene and immunotherapy companies, the company said. The expansion is expected to take place over a two-year period to support the company’s R&D activities in developing faster and more cost-effective viral vector and DNA plasmid production platforms. The first phase is slotted for its plant in Keele, England, and will expand the facility’s viral vector phase 3 and commercial manufacturing capabilities. Source: Fierce Pharma 18/4/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).